Home Cart 0 Sign in  
X

[ CAS No. 223137-87-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 223137-87-9
Chemical Structure| 223137-87-9
Chemical Structure| 223137-87-9
Structure of 223137-87-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 223137-87-9 ]

Related Doc. of [ 223137-87-9 ]

Alternatived Products of [ 223137-87-9 ]

Product Details of [ 223137-87-9 ]

CAS No. :223137-87-9 MDL No. :MFCD16621090
Formula : C17H16O2 Boiling Point : -
Linear Structure Formula :- InChI Key :YBRDFCQKQVTQKX-UHFFFAOYSA-N
M.W : 252.31 Pubchem ID :11379759
Synonyms :

Calculated chemistry of [ 223137-87-9 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.29
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 75.14
TPSA : 40.46 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.94 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.35
Log Po/w (XLOGP3) : 4.09
Log Po/w (WLOGP) : 3.28
Log Po/w (MLOGP) : 3.31
Log Po/w (SILICOS-IT) : 3.91
Consensus Log Po/w : 3.39

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.45
Solubility : 0.00899 mg/ml ; 0.0000356 mol/l
Class : Moderately soluble
Log S (Ali) : -4.65
Solubility : 0.00571 mg/ml ; 0.0000226 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.14
Solubility : 0.00183 mg/ml ; 0.00000726 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.49

Safety of [ 223137-87-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 223137-87-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 223137-87-9 ]
  • Downstream synthetic route of [ 223137-87-9 ]

[ 223137-87-9 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 223137-81-3 ]
  • [ 223137-87-9 ]
YieldReaction ConditionsOperation in experiment
57 g at 105℃; To the above white powder was added8. 00 gTetrabutyl bromide Press,Then add 300.00 mL of 48percent hydrogen bromide solution,As for the 105 ° C oil bath,Reaction overnightAfter cooling, add 500. 00 mL of deionized water,Then add 500. 00 mL of dichloromethane,After stirring for 30 minutes,The organic phase is separated,And then to 500. 00 mL deionized water,500. 00 mL saturated aqueous sodium bicarbonate solution and 500. 00 mL saturated brine to wash the organic phase,Concentrated solvent to be applied,To obtain a pink powder,The powder was recrystallized from petroleum ether / ethyl acetate (8: 2, ν / ν)57 g of a white powder was obtained,The total yield was 45percent. Using a 48percent aqueous solution of HBr in which the demethylating agent is readily accessible, is easy to store, and the reaction is mild without having to be particularly low orParticularly high temperatures, and yields higher than other methods; the method of purifying intermediates and final products is recrystallization,No longer use the higher cost, solid waste more column chromatography separation and purification methods, and the amount of solvent used significantly reduced.
Reference: [1] Tetrahedron Asymmetry, 1999, vol. 10, # 1, p. 125 - 131
[2] Catalysis Communications, 2016, vol. 81, p. 50 - 53
[3] Patent: CN105503542, 2016, A, . Location in patent: Paragraph 0025
  • 2
  • [ 223137-67-5 ]
  • [ 223137-87-9 ]
Reference: [1] Tetrahedron Asymmetry, 1999, vol. 10, # 1, p. 125 - 131
[2] Catalysis Communications, 2016, vol. 81, p. 50 - 53
[3] Patent: CN105503542, 2016, A,
  • 3
  • [ 223137-71-1 ]
  • [ 223137-87-9 ]
Reference: [1] Tetrahedron Asymmetry, 1999, vol. 10, # 1, p. 125 - 131
[2] Catalysis Communications, 2016, vol. 81, p. 50 - 53
[3] Patent: CN105503542, 2016, A,
  • 4
  • [ 458533-66-9 ]
  • [ 223137-87-9 ]
Reference: [1] Tetrahedron Asymmetry, 1999, vol. 10, # 1, p. 125 - 131
  • 5
  • [ 591-31-1 ]
  • [ 223137-87-9 ]
Reference: [1] Catalysis Communications, 2016, vol. 81, p. 50 - 53
[2] Patent: CN105503542, 2016, A,
  • 6
  • [ 116836-15-8 ]
  • [ 223137-87-9 ]
Reference: [1] Catalysis Communications, 2016, vol. 81, p. 50 - 53
[2] Patent: CN105503542, 2016, A,
  • 7
  • [ 223137-76-6 ]
  • [ 223137-87-9 ]
Reference: [1] Tetrahedron Asymmetry, 1999, vol. 10, # 1, p. 125 - 131
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 223137-87-9 ]

Aryls

Chemical Structure| 1745-89-7

[ 1745-89-7 ]

4,4'-(Propane-2,2-diyl)bis(2-allylphenol)

Similarity: 0.97

Chemical Structure| 4237-44-9

[ 4237-44-9 ]

2-(1-Phenylethyl)phenol

Similarity: 0.94

Chemical Structure| 157432-87-6

[ 157432-87-6 ]

5,11,17,23-Tetra-t-butyl-25,26,27,28-tetrahydroxycalix-4-arene stereoisomer

Similarity: 0.92

Chemical Structure| 85-27-8

[ 85-27-8 ]

4-(1-Phenylethyl)benzene-1,3-diol

Similarity: 0.92

Chemical Structure| 1948-33-0

[ 1948-33-0 ]

2-(tert-Butyl)benzene-1,4-diol(may occur to produce black solid)

Similarity: 0.92

Related Parent Nucleus of
[ 223137-87-9 ]

Spiroes

Chemical Structure| 1568-80-5

[ 1568-80-5 ]

3,3,3',3'-Tetramethyl-2,2',3,3'-tetrahydro-1,1'-spirobi[indene]-6,6'-diol

Similarity: 0.89

Chemical Structure| 171-77-7

[ 171-77-7 ]

2H-Spiro[benzofuran-3,4'-piperidine]

Similarity: 0.63

Chemical Structure| 899422-06-1

[ 899422-06-1 ]

2-Bromospiro[fluorene-9,9'-xanthene]

Similarity: 0.59

Chemical Structure| 198142-65-3

[ 198142-65-3 ]

2,7-Dibromospiro[fluorene-9,9'-xanthene]

Similarity: 0.59

Chemical Structure| 400729-14-8

[ 400729-14-8 ]

Spiro[chroman-2,4'-piperidine] hydrochloride

Similarity: 0.52